BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 12391525)

  • 21. Effects of vasopressin in septic shock.
    Ruggiero MS
    AACN Adv Crit Care; 2008; 19(3):281-7. PubMed ID: 18670203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock.
    Morales DL; Gregg D; Helman DN; Williams MR; Naka Y; Landry DW; Oz MC
    Ann Thorac Surg; 2000 Jan; 69(1):102-6. PubMed ID: 10654495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
    Lam SW; Bauer SR; Cha SS; Oyen LJ
    Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL; Walley KR
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginine vasopressin and serum nitrite/nitrate concentrations in advanced vasodilatory shock.
    Dünser MW; Werner ER; Wenzel V; Ulmer H; Friesenecker BE; Hasibeder WR; Mayr AJ
    Acta Anaesthesiol Scand; 2004 Aug; 48(7):814-9. PubMed ID: 15242424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine vasopressin in the treatment of vasodilatory septic shock.
    Holmes CL; Walley KR
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):275-86. PubMed ID: 18683474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial.
    Choong K; Bohn D; Fraser DD; Gaboury I; Hutchison JS; Joffe AR; Litalien C; Menon K; McNamara P; Ward RE;
    Am J Respir Crit Care Med; 2009 Oct; 180(7):632-9. PubMed ID: 19608718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of vasopressin in the treatment of vasodilation in shock states.
    Rozenfeld V; Cheng JW
    Ann Pharmacother; 2000 Feb; 34(2):250-4. PubMed ID: 10676834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond.
    Dünser MW; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):122-7. PubMed ID: 18443477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin use is associated with death in acute trauma patients with shock.
    Collier B; Dossett L; Mann M; Cotton B; Guillamondegui O; Diaz J; Fleming S; May A; Morris J
    J Crit Care; 2010 Mar; 25(1):173.e9-14. PubMed ID: 19682851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?
    Dünser MW; Fries DR; Schobersberger W; Ulmer H; Wenzel V; Friesenecker B; Hasibeder WR; Mayr AJ
    Anesth Analg; 2004 Jul; 99(1):201-206. PubMed ID: 15281530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of vasopressin for treating vasodilatory shock and cardiopulmonary arrest.
    Scroggin RD; Quandt J
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):145-57. PubMed ID: 19691565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.
    Argenziano M; Choudhri AF; Oz MC; Rose EA; Smith CR; Landry DW
    Circulation; 1997 Nov; 96(9 Suppl):II-286-90. PubMed ID: 9386112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamines and vasopressin during critical illness.
    Asfar P; Hauser B; Radermacher P; Matejovic M
    Crit Care Clin; 2006 Jan; 22(1):131-49, vii-viii. PubMed ID: 16399024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial.
    Torgersen C; Dünser MW; Wenzel V; Jochberger S; Mayr V; Schmittinger CA; Lorenz I; Schmid S; Westphal M; Grander W; Luckner G
    Intensive Care Med; 2010 Jan; 36(1):57-65. PubMed ID: 19756505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs.
    Voelckel WG; Raedler C; Wenzel V; Lindner KH; Krismer AC; Schmittinger CA; Herff H; Rheinberger K; Königsrainer A
    Crit Care Med; 2003 Apr; 31(4):1160-5. PubMed ID: 12682488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arginine vasopressin vs. terlipressin in the treatment of shock states.
    Singer M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):359-68. PubMed ID: 18683481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin in cardiac arrest and vasodilatory shock: a forgotten drug for new indications.
    Ben-Abraham R; Hadad E; Weinbroum AA; Efrati O; Paret G
    Isr Med Assoc J; 2003 Apr; 5(4):272-6. PubMed ID: 14509133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma copeptin levels before and during exogenous arginine vasopressin infusion in patients with advanced vasodilatory shock.
    Torgersen C; Luckner G; Morgenthaler NG; Jochberger S; Schmittinger CA; Wenzel V; Hasibeder WR; Grander W; Dünser MW
    Minerva Anestesiol; 2010 Nov; 76(11):905-12. PubMed ID: 20386508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.